Concepedia

Zaihui Zhang

ZZ

20

Publications

721

Citations

14

H-Index

1989

Active since

Affiliations

Xenon Pharmaceuticals (Canada)(Current)

SignalChem (Canada)

University of British Columbia

Novartis (United States)

Zaihui Zhang is an author at Xenon Pharmaceuticals (Canada) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1989–2023

20

Publications

20

A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors

Paul C. McDonald, Stephen Chia, Philippe L. Bédard et al. · American Journal of Clinical Oncology · 2020 · 235 citations · Full text

Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones

Zaihui Zhang, Steven J. Rettig, Chris Orvig · Inorganic Chemistry · 1991 · 72 citations

, , +11

Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1)

Jay A. Cadieux, Zaihui Zhang, Maryanne Mattice et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 41 citations · Full text

, , +6

Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia

Xiaojia Niu, Katharina Rothe, Min Chen et al. · Blood · 2021 · 38 citations · Full text

Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors

Zaihui Zhang, Kodumuru Vishnumurthy, Serguei Sviridov et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 36 citations · Full text

, , +10

Rows per page

1–5 of 20